Your browser doesn't support javascript.
loading
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium.
Busschots, Dana; Kremer, Cécile; Bielen, Rob; Koc, Özgür Muhammet; Heyens, Leen; Dercon, Eefje; Verrando, Rita; Windelinckx, Tessa; Maertens, Griet; Bourgeois, Stefan; Hens, Niel; Matheï, Catharina; Robaeys, Geert.
Afiliación
  • Busschots D; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Diepenbeek, Belgium. dana.busschots@uhasselt.be.
  • Kremer C; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium. dana.busschots@uhasselt.be.
  • Bielen R; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-Biostat), Data Science Institute, Hasselt University, Diepenbeek, Belgium.
  • Koc ÖM; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Diepenbeek, Belgium.
  • Heyens L; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Dercon E; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Diepenbeek, Belgium.
  • Verrando R; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Windelinckx T; School of NUTRIM, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Maertens G; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Diepenbeek, Belgium.
  • Bourgeois S; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Hens N; School of NUTRIM, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Matheï C; zorGGroep Zin Limburg, Hasselt, Belgium.
  • Robaeys G; zorGGroep Zin Limburg, Hasselt, Belgium.
Harm Reduct J ; 18(1): 54, 2021 05 17.
Article en En | MEDLINE | ID: mdl-34001145

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Abuso de Sustancias por Vía Intravenosa / Hepatitis C Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans / Male País/Región como asunto: Europa Idioma: En Revista: Harm Reduct J Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Abuso de Sustancias por Vía Intravenosa / Hepatitis C Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans / Male País/Región como asunto: Europa Idioma: En Revista: Harm Reduct J Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido